CJC 1295 Odin Pharma 10 x 10iu Odin Pharmaceuticals
€132.00
Composition and action of CJC 1295 Odin Pharma 10 x 10iu Odin Pharmaceuticals, profile of the main ingredient
CJC 1295 is a synthetic peptide that functions as a growth hormone-releasing hormone (GHRH) analog. It is widely used in the field of sports pharmacology due to its unique ability to stimulate the pituitary gland, leading to increased production and release of endogenous growth hormone. The product from Odin Pharmaceuticals comes in a convenient 10 x 10iu packaging, making it easy to dose for athletes.
The main ingredient, CJC 1295, binds to specific receptors in the hypothalamus and pituitary gland, prompting the secretion of growth hormone. This can lead to several significant physiological effects, making it attractive for both athletes and bodybuilders.
- Increased growth hormone levels
- Enhanced muscle mass and strength
- Improved recovery from training
- Better fat metabolism
- Improved sleep quality
Effectiveness in training, muscle adaptation and energy
The effectiveness of CJC 1295 in training and muscle adaptation cannot be overstated. As growth hormone levels rise, so does muscle protein synthesis, which is vital for muscle growth. Many users report increased lean muscle mass, making it a popular choice among those looking to enhance their athletic performance. Furthermore, an increase in growth hormone can assist in the quicker repair of muscle tissues, allowing athletes to train harder and more frequently.
Beyond muscle development, CJC 1295 also plays a crucial role in energy metabolism. By enhancing the utilization of fat as a fuel source, it helps athletes maintain energy levels during intense workouts. This dual action of promoting muscle growth while improving energy availability makes CJC 1295 one of the standout peptides for optimizing athletic performance.
How to get CJC 1295 Odin Pharma 10 x 10iu Odin Pharmaceuticals online, advantages of our store
Acquiring CJC 1295 Odin Pharma 10 x 10iu is straightforward with our store. We offer a reliable platform for athletes to purchase high-quality products, ensuring that you receive genuine CJC 1295 to maximize your training results. When you choose our store, you can expect several advantages:
- Discreet packaging for privacy
- Secure online transactions
- Fast shipping options
- 24/7 customer support for inquiries
- Competitive pricing
Ensuring that you have easy access to CJC 1295 means that you can stay consistent with your training regimen without interruption. Our streamlined online shopping experience will help you get back to focusing on your goals.
Optimal cycle duration, when to start and stop
For best results, an optimal cycle duration for CJC 1295 is typically 8 to 12 weeks. Athletes often start their cycles during a period of intense training, particularly when looking to push through plateaus in strength and muscle growth. Begin with a dosage of around 1-2 mcg/kg of body weight, administered 2-3 times a week.
It’s essential to monitor your body’s response during the cycle and adjust the dosing as needed, allowing for optimal results. Following the cycle, a break of at least 4-6 weeks is recommended to allow your body to return to baseline hormone levels before starting another cycle.
Possible adverse effects, important precautions
While CJC 1295 is generally well-tolerated, it is important to be aware of possible adverse effects. Some users may experience:
- Injection site reactions (redness or swelling)
- Water retention
- Joint pain or discomfort
- Increased appetite
- Potential for hypoglycemia
Before starting any new supplementation, it is crucial to consult with a healthcare practitioner, especially if you have pre-existing health conditions. A thorough evaluation will help ensure that CJC 1295 is suitable for you, minimizing risks and enhancing overall safety during your usage. Always adhere to recommended dosages and cycles to ensure optimal results while safeguarding your health.
| Active substance | Growth Hormone Releasing |
|---|---|
| Water Retention | Moderate |
| Hepatotoxicity | None reported |
| Lab Test | Growth Hormone levels |
| Also known as | DAC:GRF, Drug Affinity Complex: Growth Hormone Releasing Factor |
| Blood pressure | No significant impact |
| Trade name | Not available under a specific trade name |
| Storage conditions | Should be refrigerated at 2-8 degrees Celsius, avoid freezing |
| Formula | C152H252N44O42 |
| Substance class | Peptide hormone |
| Main action | Increases plasma levels of growth hormone |
| Half-life | Approximately 6-8 days |
| Dosage (medical) | Typically 1-2 mg once or twice a week |
| Dosage (sports) | 1-2 mg two times a week |
| Effects | Increased muscle growth, enhanced fat loss, improved skin elasticity, strengthened immune system |
| Side effects | Irritation at injection site, water retention, tingling sensations, occasional dizziness |
| Use in sports | Used to enhance performance and accelerate recovery |
| Manufacturer | Odin Pharmaceuticals |
| Packing | 10 x 10iu [2mg/vial] |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |


Reviews
There are no reviews yet.